drugset / Trial / NCT03348423
Evaluation of DEX-IN During Outpatient Procedures
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study is to evaluate the analgesic efficacy of DEX-IN compared with placebo and active control (fentanyl), in subjects undergoing painful outpatient and office based procedures.
Timeline
- Start
- 2017-11-15
- Primary completion
- 2018-01-18
- Completion
- 2018-01-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 50 ug | Intranasal |
| Comparator | Fentanyl | Other / unclassified | 50 ug | Intravenous |
Indications
No indication recorded.